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Background: Previous studies have demonstrated Aboriginals are less likely to receive a renal transplant in
comparison to Caucasians however whether this applies to the entire population or specific subsets remains
unclear. We examined the effect of age on renal transplantation in Aboriginals.
Methods: Data on 30,688 dialysis (Aboriginal 2,361, Caucasian 28, 327) patients obtained between Jan. 2000 and
Dec. 2009 were included in the final analysis. Racial status was self-reported. Cox proportional hazards, the Fine and
Grey sub-distribution method and Poisson regression were used to determine the association between race, age
and transplantation.
Results: In comparison to Caucasians, Aboriginals were less likely to receive a renal transplant (Adjusted HR 0.66
95% CI 0.57-0.77, P < 0.0001) however after stratification by age and treating death as a competing outcome, the
effect was more predominant in younger Aboriginals (Age 18–40: 20.6% aboriginals vs. 48.3% Caucasians
transplanted; aHR 0.50(0.39-0.61), p < 0.0001, Age 41–50: 10.2% aboriginals vs. 33.9% Caucasians transplanted; aHR
0.46(0.32-0.64), p = 0.005, Age 51–60: 8.2% aboriginals vs. 19.5% Caucasians transplanted; aHR0.65(0.49-0.88), p = 0.01,
Age >60: 2.7% aboriginals vs. 2.6% Caucasians transplanted; aHR 1.21(0.76-1.91), P = 0.4, Age X race interaction
p < 0.0001). Both living and deceased donor transplants were lower in Aboriginals under the age of 60 compared
to Caucasians.
Conclusion: Younger Aboriginals are less likely to receive a renal transplant compared to their Caucasian
counterparts, even after adjustment for comorbidity. Determination of the reasons behind these discrepancies and
interventions specifically targeting the Aboriginal population are warranted.Background
While the number of Aboriginal patients with end-stage
renal disease (ESRD) requiring dialysis in Canada has
increased rapidly over the last few decades, a similar
growth in renal transplantation rates for this population
has not occurred [1]. Transplantation is the ideal thera-
peutic option for the ESRD population with a significant
survival advantage, decreased morbidity and cost, and
improved quality of life [2]. The Aboriginal ESRD popula-
tion is in general younger than their Caucasian counter-
parts and often reside in rural communities [3]. Previous
studies have shown, ESRD for the Aboriginal population* Correspondence: msood99@gmail.com
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distribution, and reproduction in any mediumon dialysis typically requires displacement from their com-
munities and disruption of their lifestyle [4].
Despite the fact that the Aboriginal population with
ESRD seem well suited for renal transplantation, they con-
tinue to receive transplants at a significantly lower rate
compared to their Caucasian counterparts [5]. Decreased
rates of both living and deceased donor transplants have
been documented in various regions across Canada, and
the largest international study to date indicates Aboriginals
receive transplants at roughly half the rate compared to the
Caucasian ESRD population [6,7]. There are many theories
that have been postulated as to why this discrepancy exists
such as a decrease in living donors, residing in remote com-
munities or low socioeconomic status but to date no clear
reasons have been brought to the forefront. In renal trans-
plantation, age has been found to be an important effecttral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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strated in elderly women [8].
With this in mind, we set out to examine age as an ef-
fect modifier on the rates of renal transplantation in
Aboriginal compared to the Caucasian population.
Methods
Study design
All adults (>18 years old) who received dialysis therapies
or a renal transplantation from the Canadian Organ Re-
placement Registry (CORR) between January 1, 2000
and December 2009 were included in our analysis. In
patients who received greater than one renal transplant,
only the first transplant was included in our analysis.
The Canadian CORR captures data on all dialysis
patients in Canada (except Quebec) and includes infor-
mation on demographics, death, dialysis modality,
comorbidities and transplantation. CORR data has been
well validated for the study of outcomes [9]. This study
was reviewed by the Research Board and the Hospital
Ethics Board at St. Boniface Hospital in Winnipeg,
Manitoba. All data was de-identified, retrospective from
the CORR.
Definitions
Racial information is recorded by health care providers
based on patient self report. Dialysis modality was deter-
mined 90 days after dialysis initiation and categorized as
hemodialysis or peritoneal dialysis. Co-morbid illnesses
included a history of angina, myocardial infarction, dia-
betes mellitus, peripheral vascular disease, malignancy,
hypertension medication usage, cigarette smoker, lung
disease and stroke. Causes of ESRD included ischemia,
diabetes mellitus, glomerulonephritis, interstitial disease,
polycystic kidney disease, obstruction, other and un-
known. Provinces and territories were categorized as
geographic regions as follows: Atlantic (New Brunswick,
Nova Scotia, Prince Edward Island, Newfoundland),
Central (Ontario), Prairies (Alberta, Saskatchewan,
Manitoba, Nunavut, Northwest Territories), Pacific
(British Columbia, Yukon). Pre-dialysis care was the
length of time from the first Nephrologist visit to the
initiation of dialytic therapy. Distance to centre was cal-
culated as the direct linear distance in kilometres be-
tween a patients postal code from their primary
residence at dialysis initiation to the nearest dialysis pro-
vider using Vincenty’s formula [10]. Comorbidities and
laboratory data were ascertained at the onset of ESRD.
Outcome measures
The outcome of interest was renal transplantation with
the competing event of mortality. In patients who
received greater than one renal transplant, only the first
was included in the analysis.Statistical analyses
Continuous variables of interest were summarized as
mean or medians with standard deviation or inter-quartile
range as appropriate. Differences in baseline characteris-
tics were determined by student’s t-test or the Kruskal
Wallis test for continuous variables and chi-square or the
Mann–Whitney test for dichotomous variables.
To assess our outcome of renal transplantation, we uti-
lized traditional Cox proportional hazards and the modi-
fied risks regression according to Fine and Gray to account
for competing risks [11]. We performed sequential adjust-
ment for demographics, age, sex, race, distance from cen-
ter, pre-dialysis care, geographic region, comorbidity, BMI,
cause of ESRD, serum albumin, and dialysis modality. The
competing risk model by Fine and Gray yields an adjusted
sub hazard ratio (aSHR). To assess whether age was an ef-
fect modifier for renal transplantation, a formal age X race
interaction term was examined in crude and adjusted mod-
els by both methodologies and found to be statistically sig-
nificant (p < 0.0001). Based on the distribution of
transplantation events, age was further stratified into age
groups of 18–40, 41–50, 51–60, >60 years old [12]. As
there were a relatively small number of events in the Abo-
riginal group, additional adjusted models were constructed
as follows: model 1 sex, BMI, region, model 2 co-morbid-
ities, and model 3 cause of ESRD, serum albumin, distance
from centre, modality, pre-dialysis care.
We determined relative rate ratios (RRR) of total renal
transplantation and the subgroups of living or deceased
donor organs using Poisson loglinear regression. When
all renal transplants were examined, the models were
adjusted for similar variables as above. In separate mod-
els examining deceased and living donors, models were
adjusted for sex, diabetes, vascular disease, region, pre-
dialysis care, serum albumin and distance to centre due
to a limited number of events.
Multiple imputation was employed for missing values
with a random draw from the predictive distribution from
an imputation model repeated ten times (see Figure 1).
There were no differences in missing data between races.
An iterative Markov chain Monte Carlo (MCMC) method
was used and pooled estimates of 10 rounds of imputation
reported. Models were repeated with original and imputed
data to confirm imputation did not significantly alter point
estimates.
Analyses were performed using PASW Version 18 and
the Fine and Grey analyses were performed using R. All
hypothesis tests were two sided with statistical signifi-
cance to find as having a P value of <0.05.
Results
Our analytic cohort consisted of 30, 688 [Aboriginal 2,361
(7.7%), Caucasian 28,327(92.3%)] patients between Jan
2000 and Dec 2009 in the CORR database. Loss to follow
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Figure 1 Development of the study cohort. ESRD end stage renal disease, CORR Canadian organ Replacement Registry, BMI body mass index.
Promislow et al. BMC Nephrology 2013, 14:11 Page 3 of 7
http://www.biomedcentral.com/1471-2369/14/11up was minimal (12 Aboriginals and 117 Caucasians) and
they were excluded from the analysis. Missing data ele-
ments and proportion imputed are presented in Figure 1.
The median follow up time for Aboriginals was 2.96 years
(IQR 1.51-5.19) and 2.64 years (IQR 1.2-4.86) for Cauca-
sians. Aboriginals were younger (55 vs. 67 mean age), and
more likely to be female (50 vs. 40%), with a higher BMI
(29.4 vs. 27.8 mean) and reside in rural settings (65.1 vs.
26.5%) than Caucasians. Aboriginals on dialysis reside in
the Prairies and they are less likely to have a history of car-
diac disease (angina, ACS, pulmonary edema or CABG) or
malignancy at dialysis initiation. Conversely they are more
likely to have ESRD due to diabetes mellitus and laboratory
derangements at dialysis initiation such as anemia, hypoal-
buminemia and hyperphosphatemia. Aboriginals were also
more likely to initiate dialysis via a central venous catheter
and less likely to be on PD 90 days after dialysis initiation
(see Table 1).
During the study period, 3,529 (11.5%) received a renal
transplant. 203 (8.6%) of Aboriginals with ESRD received
a transplant compared to 3,336 (11.7%) of Caucasians.
Among Aboriginals age 18–40, only 20.6% underwent
renal transplantation compared to 48.3% of Caucasians.
This trend was less prominent in the age 51–60 category
as 8.2% of Aboriginals were transplanted compared to
19.5% of Caucasians and attenuated in the over 60 age
group, albeit with a small number of transplants at 2.7
and 2.6%, respectively. In the time to event analyses dif-
ferences were observed between the traditional cox
models (aHR) and the Fine and Grey method (sHR)
accounting for the competing risk of mortality and thiseffect was more evident in individuals less than 50 (age
18–40: sHR 0.50 95%CI 0.39-0.61, p < 0.0001 vs. aHR
0.62 95%CI 0.49-0.78, p < 0.0001; age 41–50: sHR 0.46
95%CI 0.32-0.64, p < 0.0001 vs. aHR 0.62 95%CI 0.44-
0.87, p = 0.005) (see Table 2). Additional models 1 thru 3
yielded point estimates consistent with our fully adjusted
models (see Additional file 1: Table S1).
Similar differences were observed when examining
crude and adjusted relative rate ratios (RRR) for renal
transplantation (see Figure 2). The adjusted relative rate
ratio of renal transplantation for Aboriginals age 18–40
was nearly half that of Caucasians (adjusted RRR 0.49
95%CI 0.39-0.63, p < 0.0001) (see Figure 2). This trend
was less prominent in the age 51–60 category (adjusted
RRR 0.65 95%CI 0.48-0.87, p = 0.004) and again attenu-
ated in the over 60 age group (adjusted RRR 1.14 95%CI
0.73-1.77, p = 0.6).
Information regarding the source of the organ, either
living or deceased donor, is presented in Table 3. The
adjusted relative rate ratios of living and deceased donor
transplants were lower in Aboriginals under the age of
60 compared to Caucasians. This discrepancy was con-
siderably more apparent among living donor transpla-
ntation (Age 18–40 adjusted RRR: 0.32 95%CI 0.22-0.47,
P < 0.0001) than deceased donors (Age 18–40 adjusted
RRR: 0.55 95%CI 0.39-0.76, P < 0.0001).
Discussion
In this large, contemporary Canadian cohort study we
demonstrated that age is a significant and important fac-
tor in receipt of a renal transplantation in Aboriginal
Table 1 Comparison of baseline characteristics among Aboriginals and Caucasians
Characteristic
Aboriginal Caucasian P Value
N 2,361 28,327
Age (± SD) 55.25 ± 14.1 66.5 ± 14.5 <0.0001
Sex % female (N) 50.0(1180) 39.8(11265) <0.0001
BMI (± SD) 29.4 ± 6.8 27.8 ± 7.1 <0.0001
Distance to centre in km(IQR) 167.5(217) 12.0 (47) <0.0001
Rural % (N) 65.1(1531) 26.5(7493) <0.0001
Median number of days with pre-dialysis care (IQR) 108 (588) 119(790) 0.6
Any pre-dialysis care % (N) 73.7(1739) 71.9(20366) 0.07






Angina 17.4(410) 22.1(6248) <0.0001
Acute coronary syndrome 17.4(411) 21.9(6195) <0.0001
Pulmonary edema 30.7(582) 27.9(6177) 0.01
Diabetes mellitus type 1 0.9(21) 0.7(210) 0.4
Diabetes mellitus type 2 70.8(1671) 43.2(12246) <0.0001
Stroke 12.6(297) 14.3(4049) 0.02
Peripheral vascular disease 21.7(513) 19.5(5516) 0.009
Malignancy 4.5(107) 13.5(3810) <0.0001
Lung disease 7.9(187) 12(3389) <0.0001
Hypertension medications 80.3(1896) 80.6(22820) 0.8
Current smoker 23.3(549) 13.4(3803) <0.0001
CABG 7.9(187) 14(3961) <0.0001
Cause of ESRD % (N)
Hypertension 6.6(157) 24(6797) <0.0001
Diabetes mellitus 64.2(1516) 34.5(9775) <0.0001
Glomerulonephritis 16(378) 14.2(4021) 0.02
Obstruction 1.3(30) 3.2(913) <0.0001
Interstitial 0.9(22) 1.1(315) 0.5
Polycystic kidney disease 0.9(22) 4.9(1396) <0.0001
Other 3.7(88) 8.6(2430) <0.0001
Unknown 6.3(148) 9.5(2680) <0.0001
Serum Albumin g/L (± SD) 28.2 ± 6.9 31.8 ± 6.8 <0.0001
Hemoglobin g/L (± SD) 93.5 ± 18.1 100.8 ± 17.2 <0.0001
Phosphorous mmol/L (± SD) 2.21 ± 0.82 1.96 ± 0.73 <0.0001
Peritoneal dialysis % (N) 19.6(463) 21.6(6120) 0.02
AVF/AVG % (N) 8.9(210) 11.0(3130) 0.001
N = cohort size, SD standard deviation, km kilometer, IQR interquartile range, CABG coronary artery bypass graft, ESRD end stage renal disease, g/L grams per litre,
mmol/L milimole per litre, AVF arteriovenous fistula, AVG arteriovenous graft.
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Table 2 Crude proportions and adjusted hazard ratio for receiving a renal transplant by age groups in Aboriginals by
traditional Cox and competing risk models
AGE group Proportion transplanted % (N) Competing Risks (95% CI) COX (95% CI)
Aboriginal Caucasian
18-40 20.6 (83) 48.3 (1037) 0.50(0.39-0.61), P < 0.0001 0.62(0.49-0.78), p < 0.0001
41-50 10.2 (42) 33.9 (892) 0.46(0.32-0.64), P < 0.0001 0.62(0.44-0.87), p = 0.005
51-60 8.2 (55) 19.5 (899) 0.65(0.49-0.88), P = 0.005 0.68(0.50-0.92), p = 0.01
>60 2.7 (23) 2.6 (508) 1.21(0.76-1.91), P = 0.4 1.22(0.78-1.90), P = 0.4
RACE X Age interaction P < 0.0001 by both COX and competing risks methods.
Across each age category, Caucasians were the referent.
Adjusted for sex, co-morbidity, BMI, albumin, distance, cause of ESRD, PD, pre-dialysis care, region.
HR hazard ratio, CI confidence interval, N cohort size.
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ticular, the age at which the most benefit is likely to be
derived from renal transplantation, are less likely than
Caucasian counterparts to receive transplantation. The
results of this study, coupled with the rapidly-growing
population of young Aboriginals in Canada, suggests
that the significantly reduced rate of renal transplant-
ation in the young Aboriginal population may continue
to play a significant role in the burden of chronic disease
and resultant health challenges they face if some degree
of targeted intervention is not undertaken.
Over the last decade, the likelihood of undergoing a
renal transplantation is significantly lower in the younger
Aboriginal population compared to their Caucasian
counterparts. Aboriginals compared to Caucasians be-
tween the age of 18 to 40 are less than half as likely to
receive a graft (adjusted RRR 0.49 95%CI 0.39-0.63, p <
0.0001). This discrepancy decreases with age as trans-
plant rates become similar in individuals over the age of
60 albeit with few transplants conducted in that age cat-
egory. This observation remained consistent after adjust-
ment for confounding variables in time to eventFigure 2 Unadjusted and adjusted relative rate ratios for renal transp
categories. Adjusted for sex, co-morbidity, BMI, albumin, distance from cenanalyses, after accounting for competing outcomes and
when examining ESRD population rates.
Numerous reports have described reductions in renal
transplantation in Aboriginal peoples [5,7,13,14]. Earlier
reports examining data from the 1990s and early 2000s
demonstrated Aboriginals have roughly half the chances
of undergoing renal transplantation. Unfortunately our
study demonstrates that after a decade little has chan-
ged. Despite differing health care delivery systems and
ancestral background of Indigenous peoples, reports
from Australia, New Zealand and the United states all
demonstrate similarly low transplantation rates [5]. Re-
cently, reduced transplant rates have been reported in
Canada’s Aboriginal children and adolescents [14]. Al-
though consistent, no studies have illustrated this dis-
crepancy differs with age.
Our analysis included models incorporating competing
outcomes allowing the elucidation of important differences
in effect estimates. Recently a report of over 1 million
ESRD patients in United States, demonstrated reduced sur-
vival in African-Americans under the age of 50, largely at-
tributable to the a lower transplantation rate as patientslantation in Aboriginals and Caucasians according to age
tre, cause of ESRD, PD, pre-dialysis care, region.
Table 3 Unadjusted and adjusted relative rate ratios rates for living and deceased donor renal transplantation in
Aboriginals and Caucasians according to age categories
AGE group Living donor: Relative risk ratio (95% CI), p value Deceased donor: Relative risk ratio (95% CI), p value
Crude Adjusted Crude Adjusted
18-40 0.32(0.22-0.47), p < 0.0001 0.32 (0.22-0.48), p < 0.0001 0.53(0.39-0.72), P < 0.0001 0.55(0.39-0.76), P < 0.0001
41-50 0.21(0.12-0.39), p < 0.0001 0.30(0.16-0.55), P < 0.0001 0.44(0.30-0.63), p < 0.0001 0.50(0.33-0.75), P = 0.001
51-60 0.32(0.19-0.54), p < 0.0001 0.44(0.26-0.76), p = 0.003 0.47(0.33-0.68), P < 0.0001 0.70(0.47-1.03), P = 0.07
>60 0.97(0.46-2.10),p = 0.9 1.05(0.47-2.31), P = 0.9 0.70(0.36-1.36), p = 0.3 0.95(0.47-1.91), P = 0.9
Adjusted for sex, diabetes, vascular disease, region, pre-dialysis care, albumin, distance.
Across each age category, Caucasians were the referent.
CI confidence interval.
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experience mortality on dialytic therapies [15]. This observa-
tion was attributed to the use of adjusted models accounting
for competing outcomes as in the present analysis. In popula-
tions with differential rates of an outcome, traditional Cox
models would censor patients; effectively treating them all
equally (termed informative censoring). Employing competing
risk models yields an effect estimate for transplantation that
accounts for mortality differences between the Aboriginal
population and Caucasian populations [16,17]. This is illu-
strated by the differences in the point estimate for transplant-
ation in Aboriginals under the age of 50. With traditional Cox
models, the adjusted HR for Aboriginals age 18–40 is 0.62
(95%CI 0.49-0.78) compared to the competing risks adjusted
HR of 0.50 (95%CI 0.39-0.61). This is suggestive of mortality
differences between the two populations however it should be
noted there is considerable uncertainty in the point estimates
(as illustrated with the overlap of the 95% confidence inter-
vals). Differential dialysis mortality among the populations has
recently been demonstrated to be modality dependent with
Aboriginals on peritoneal dialysis having a higher modality
compared to Caucasians [18]. This effect was not observed on
hemodialysis.
While reduced access to transplantation is clearly a
finding that crosses multiple minority groups in differing
regions of the world, in Canada it is the young Aborigi-
nal population in whom this discrepancy is most pre-
dominant. We found both deceased and living donor
transplants were less likely in Aboriginals. Furthermore
in Aboriginals, the adjusted relative rate ratios of living
donor transplant were nearly half that of deceased
donors (0.32 (95%CI 0.22-0.48) vs. 0.55(95%CI 0.39-
0.76)). The reasons behind this reduced rate are often
complex involving patient, graft and health delivery-
related factors. A report from Alberta, demonstrated
Aboriginals were more likely to be in the process of
evaluation as opposed to being list as ready or not suit-
able [19]. Furthermore the median duration for trans-
plant evaluation was 954 days compared to 596 days in
Caucasians. In a recent study from Manitoba, Aboriginal
potential donors were often excluded due to non-
medical reasons, such as loss of contact [6]. Our findingsare consistent with previous studies and further demon-
strate reduced Aboriginal deceased and living donor
transplantation is not limited to the Prairie Provinces
alone. Other factors behind the reduced transplant rate
may include lower socioeconomic status, language and
cultural barriers including mistrust, discrimination, and
belief in traditional healing methods [4]. Difficulties in
health care delivery such as residing in a rural commu-
nity and the complexity and time involved in evaluation,
follow up, and investigations also significantly contribute
[20,21]. Aboriginals have similar rates of referral for
renal transplantation but are much more likely to be lost
to follow up or not complete the series of steps required
to be listed on the active transplant recipient list [19].
Age has been previously identified as an important ef-
fect modifier for transplantation in other populations
[8,15]. Gender disparities have been well described in the
transplant literature as elderly woman are much less likely
to receive a renal transplant compared to elderly men [8].
Now that a specific subgroup of the Aboriginal ESRD
population, namely the younger individuals, has been iden-
tified as the group least likely to receive a renal transplant,
race-specific targeted interventions may aid in reducing this
disparity. To address the increased length of time potential
Aboriginal transplant recipients spend in the post-referral
pre-wait list stage, attempts should be made to streamline
the workup process as many patients must currently travel
long distances, multiple times for various appointments
and tests. The implementation of a nationwide program,
with guided input from Aboriginal figures who may better
understand the potential cultural barriers currently in place,
needs to be strongly considered before this problem esca-
lates further. A toolkit prototype designed primarily by
Aboriginal people has been developed in New Brunswick,
Canada in order to provide culturally-sensitive and relevant
information for Aboriginal patients starting on dialysis [22].
Depending on the success of this project, a similar under-
taking for the potential transplant population might merit
consideration. Education need not only be provided to po-
tential recipients but also to donors as well; given the dwin-
dling supply of deceased donor kidneys, of which most
come from the majority Caucasian population and thus
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effort needs to be made to identify potential living donors
and understand the barriers that arise that prevent them
from ultimately donating. While these represent possible
factors, these beliefs may be individualized and are not ne-
cessarily generalizable to the entire Aboriginal population.
There are several potential limitations to this study that
should be considered. As this is a retrospective analysis,
attempts were made to adjust for confounding although
there may still be residual effects unaccounted for, including
socioeconomic status, education level and rates of non-ad-
herence. Given the primary outcome measure of time to
renal transplantation, we have no knowledge of outcomes
post-transplant and whether further racial discrepancies exist
at that stage. Studies have shown that Aboriginal transplant
recipients have decreased long-term graft survival and also
that living donors may be at increased risk post-transplant of
hypertension and diabetes [23]. Any potential adverse donor
outcomes are particularly important if a focus on increasing
the number of Aboriginal living donors is to be taken.
Conclusion
We found that age is an important effect modifier in de-
termining whether Aboriginals in Canada are likely to
undergo renal transplantation. Younger Aboriginals are
significantly less likely to receive transplant, a procedure
with known improvements in mortality, quality of care
and cost effectiveness. Interventions specifically target-
ing the Aboriginal population are warranted.
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